The Breast Cancer Channel

Explore the latest updates, including expert interviews and features

The Breast Cancer Channel on VJOncology is supported by Gilead. These supporters have no influence over the production of the content.

Latest Videos Topics Subtype Breast Cancer Sessions Conferences Features Podcasts ESMO Breast 2023 Editorial Board

Welcome to the Breast Cancer Channel!

VJOncology brings you the latest updates in the field of breast cancer, keeping you up-to-date with the most exciting developments with video interviews, podcasts, and roundtable discussions, and more.

Reporting from key international congresses alongside our expert Editorial Board, catch up on the key advances in breast cancer, including the use of novel treatment approaches, key trial updates as well as the emerging role of treatment de-escalation.

Breast Cancer Videos by Topic

Immuno-Oncology
Surgery
Trial Updates
Molecular Profiling
Screening
1:07
NeoTRIP: EFS in neoadjuvant atezolizumab with taxane/carboplatin ± anthracycline in high-risk TNBC
Kevin Kalinsky • 22 Oct 2023
1:24
Novel treatment options for HER2-low breast cancer
Eva Ciruelos • 23 Oct 2023
2:14
Updates in metastatic triple-negative breast cancer at ESMO 2023
Eva Ciruelos • 23 Oct 2023
1:36
Real-word efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer
Kevin Kalinsky • 22 Oct 2023
View All Videos
5:35
EU Cancer Plan and what it means for prostate cancer
Tit Albreht • 29 Mar 2023
0:57
Highlights from St. Gallen BCC 2023
Lisa Carey • 17 Mar 2023
0:57
Role of axillary dissection in breast cancer
Eun-Sook Lee • 17 Mar 2023
1:40
Controversies and uncertainties in the surgical management of breast cancer
Eun-Sook Lee • 17 Mar 2023
View All Videos
1:07
NeoTRIP: EFS in neoadjuvant atezolizumab with taxane/carboplatin ± anthracycline in high-risk TNBC
Kevin Kalinsky • 22 Oct 2023
1:04
5-year monarchE results: abemaciclib + ET in high-risk EBC
Kevin Kalinsky • 22 Oct 2023
1:32
The effect of MCED blood tests on patient screening and mental wellbeing
Tom Beer • 22 Oct 2023
3:06
Prognostic score in early HR+/HER2- breast cancer: RS, factors, mutations, histology
Oleg Gluz • 22 Oct 2023
View All Videos
3:06
Prognostic score in early HR+/HER2- breast cancer: RS, factors, mutations, histology
Oleg Gluz • 22 Oct 2023
2:05
BRCA-DIRECT: a digitized information hub for women with BC seeking germline genetic testing
Bethany Torr • 22 Oct 2023
2:15
I-SPY2.2: emerging biomarkers in breast cancer
Denise Wolf • 4 Jun 2023
2:28
Improving breast cancer treatment: incorporating immune predictors for better outcomes
Denise M. Wolf • 4 Jun 2023
View All Videos
1:32
The effect of MCED blood tests on patient screening and mental wellbeing
Tom Beer • 22 Oct 2023
1:23
Latest advances in immuno-oncology research in ER+ breast cancer
Justin Balko • 12 May 2023
3:55
Is it possible to predict who will benefit the most from IO in TNBC?
Justin Balko • 12 May 2023
0:37
Improving breast cancer outcomes with NGS sequencing
Paraic Kenny • 16 Apr 2023
View All Videos

Breast Cancer Videos by Conference

ASCO 2023
ESMO Breast 2023
St Gallen 2023
AACR 2023
SABCS 2022
ASCO 2022
0:41
The role of targeted therapies in HER2+ and HR+ breast cancer
Yutaka Yamamoto • 4 Jun 2023
2:15
I-SPY2.2: emerging biomarkers in breast cancer
Denise Wolf • 4 Jun 2023
5:07
What is the role of CDK4/6 inhibitors in early breast cancer?
Michael Gnant • 6 Jun 2023
2:27
NeoALTTO: HER2/CEP17 ratio as a predictive biomarker in HER2+ breast cancer
Michael Gnant • 8 Jun 2023
View All Videos
0:44
ADCs in early breast cancer
Sung-Bae Kim • 11 May 2023
3:24
What to look forward to in breast cancer at ASCO 2023
Hope Rugo • 12 May 2023
1:48
Navigating treatment decisions for patients with HR+/ HER- mBC
Komal Jhaveri • 11 May 2023
2:06
Exploring novel therapeutic approaches in HR+/ HER2- mBC
Komal Jhaveri • 11 May 2023
View All Videos
0:42
St Gallen BCC 2023 highlights
Walter Weber • 17 Mar 2023
1:54
Hot topics at St Gallen BCC
Eva Ciruelos • 16 Mar 2023
1:11
Unmet needs in the use of CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer
Eva Ciruelos • 16 Mar 2023
0:57
Highlights from St. Gallen BCC 2023
Lisa Carey • 17 Mar 2023
View All Videos
1:10
Do ADCs have a future in treating breast cancer?
Filipa Lynce • 17 Apr 2023
1:14
Biopsy analyses from the TALAVE trial of induction talazoparib
Filipa Lynce • 17 Apr 2023
2:47
TALAVE: induction talazoparib with PARP inhibition in breast cancer
Filipa Lynce • 17 Apr 2023
0:37
Improving breast cancer outcomes with NGS sequencing
Paraic Kenny • 16 Apr 2023
View All Videos
1:08
4-year MonarchE results: increasing benefits with abemaciclib + ET for ER+/HER2- high-risk early BC
Patrick Neven • 12 Dec 2022
1:17
Key trial updates in SERDs in ER+/HER2- breast cancer from SABCs 2022
Patrick Neven • 12 Dec 2022
1:02
Results of EMBER-2: imlunestrant two weeks prior to surgery for ER+/HER2- early stage breast cancer
Patrick Neven • 12 Dec 2022
0:51
EMBER-2: preoperative imlunestrant for ER+/HER2- early stage breast cancer
Patrick Neven • 12 Dec 2022
View All Videos
3:01
Assessing elacestrant in ctDNA-positive patients with ER+ breast cancer
Thomas Meyskens • 30 May 2022
4:29
Pertuzumab, trastuzumab and cyclophosphamide in older patients with HER2+ breast cancer
Thomas Meyskens • 30 May 2022
2:35
AMEERA-6: Amcenestrant, a novel SERD, in HR+ breast cancer
Thomas Meyskens • 30 May 2022
1:08
DESTINY-Breast04: A ground-breaking trial in HER2-low breast cancer
Thomas Meyskens • 30 May 2022
View All Videos

The Breast Cancer Channel on VJOncology is supported by Gilead.

These supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Breast Cancer Channel, please contact us.
The content of VJOncology is intended for healthcare professionals